Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2024-01-01falseNo description of principal activity00falsefalse 06007551 2024-01-01 2024-12-31 06007551 2023-01-01 2023-12-31 06007551 2024-12-31 06007551 2023-12-31 06007551 c:CompanySecretary1 2024-01-01 2024-12-31 06007551 c:Director1 2024-01-01 2024-12-31 06007551 c:Director1 2024-12-31 06007551 c:Director2 2024-01-01 2024-12-31 06007551 c:Director2 2024-12-31 06007551 c:RegisteredOffice 2024-01-01 2024-12-31 06007551 d:CurrentFinancialInstruments 2024-12-31 06007551 d:CurrentFinancialInstruments 2023-12-31 06007551 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 06007551 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 06007551 d:ShareCapital 2024-12-31 06007551 d:ShareCapital 2023-12-31 06007551 d:RetainedEarningsAccumulatedLosses 2024-12-31 06007551 d:RetainedEarningsAccumulatedLosses 2023-12-31 06007551 c:FRS102 2024-01-01 2024-12-31 06007551 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 06007551 c:AbridgedAccounts 2024-01-01 2024-12-31 06007551 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 06007551 e:USDollar 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: 06007551









KAZPHOSPHATE LIMITED







UNAUDITED

DIRECTORS' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

 
KAZPHOSPHATE LIMITED
 
 
COMPANY INFORMATION


Directors
Steven Landes 
Marina Eden 




Company secretary
Landes Limited



Registered number
06007551



Registered office
123 Pall Mall
St. James's

London

SW1Y 5EA





 
KAZPHOSPHATE LIMITED
 

CONTENTS



Page
Directors' Report
1
Statement of Comprehensive Income
2
Balance Sheet
3
Notes to the Financial Statements
4 - 5


 
KAZPHOSPHATE LIMITED
 
 
 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

The directors present their report and the financial statements for the year ended 31 December 2024.

Directors' responsibilities statement

The directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 In preparing these financial statements, the directors are required to:


select suitable accounting policies for the Company's financial statements and then apply them consistently;

make judgments and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Directors

The directors who served during the year were:

Steven Landes (appointed 19 January 2009)
Marina Eden (appointed 29 April 2021)

Small companies note

In preparing this report, the directors have taken advantage of the small companies exemptions provided by section 415A of the Companies Act 2006.

This report was approved by the board on 29 September 2025 and signed on its behalf.
 



................................................
Steven Landes
Director

Page 1

 
KAZPHOSPHATE LIMITED
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024

2024
2023
Note
$
$

Turnover
  
11,678
-

Gross loss
  
11,678
-

  
11,678
-

Administrative expenses
  
(258,420)
(429,470)

Loss before taxation
  
(246,742)
(429,470)

Loss for the financial financial year
  
(246,742)
(429,470)

Other comprehensive income for the year
  

Total comprehensive income for the year
  
(246,742)
(429,470)

The notes on pages 4 to 5 form part of these financial statements.

Page 2

 
KAZPHOSPHATE LIMITED
REGISTERED NUMBER: 06007551

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note
$
$

  

Current assets
  

Debtors
  
54,342
55,275

Cash at bank and in hand
  
1,241,620
1,488,812

  
1,295,962
1,544,087

Creditors: amounts falling due within one year
 6 
(48,503)
(49,885)

Net current assets
  
 
 
1,247,459
 
 
1,494,202

Total assets less current liabilities
  
1,247,459
1,494,202

Net assets
  
1,247,459
1,494,202


Capital and reserves
  

Called up share capital 
  
98,392
98,392

Profit and loss account
  
1,149,067
1,395,810

  
1,247,459
1,494,202


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 29 September 2025.




Steven Landes
Marina Eden
Director
Director

The notes on pages 4 to 5 form part of these financial statements.

Page 3

 
KAZPHOSPHATE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Kazphosphate Limited is a private company, limited by shares, registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A) of the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is USD.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

 
2.3

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.4

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.5

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 4

 
KAZPHOSPHATE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

3.


Employees

The average monthly number of employees, including directors, during the year was 0 (2023 - 0).


4.


Debtors

2024
2023
$
$


Other debtors
54,342
55,275

54,342
55,275



5.


Cash and cash equivalents

2024
2023
$
$

Cash at bank and in hand
1,241,620
1,488,812

1,241,620
1,488,812



6.


Creditors: Amounts falling due within one year

2024
2023
$
$

Accruals and deferred income
48,503
49,885

48,503
49,885



7.


Controlling party

The company is controlled by Ms A Yessim and Mr G Yessenov.

 
Page 5